The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Viveve Medical
VIVE
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.220100
0
0.00%
At close: Jan 18, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Viveve Medical (VIVE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Viveve Medical (OTC:VIVE) Stock
Viveve Medical Stock (OTC: VIVE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 18, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, January 17, 2023
Nasdaq Edges Higher; Neovasc Shares Jump
Lisa Levin
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Lisa Levin
Viveve Medical shares are trading lower after...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
Vandana Singh
Viveve Medical To Seek Strategic Alternatives And Will Be Delisted From Nasdaq; Company Announced Treatment For Female Stress Urinary Incontinence Did Not Meet Primary Endpoint
Charles Gross
Friday, December 23, 2022
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Friday, December 16, 2022
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, December 12, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, December 02, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, November 29, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, November 17, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, November 16, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, November 11, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, November 10, 2022
Viveve Medical Q3 EPS $(0.59) Beats $(0.66) E...
Benzinga Newsdesk
Earnings Scheduled For November 10, 2022
Benzinga Insights
Monday, October 24, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, October 12, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, October 04, 2022
Viveve Announces Notice Of Allowance For Seco...
Benzinga Newsdesk
Tuesday, September 27, 2022
Viveve Launches Rebranding Initiative To Refl...
Benzinga Newsdesk
Thursday, August 11, 2022
Viveve Medical Q2 EPS $(0.67) Down From $(0.4...
Benzinga Newsdesk
Earnings Scheduled For August 11, 2022
Benzinga Insights
Thursday, June 30, 2022
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Lisa Levin
Wednesday, June 29, 2022
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, June 28, 2022
Ten Stocks Trending on Discord for Monday June 27, 2022: HOOD, EVFM, TSLA, NXTP, AGRX, VIVE, XNCR, COIN, CHWY, NKE
Charles Gross
Monday, June 27, 2022
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Lisa Levin
Thursday, May 26, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, May 25, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Thursday, May 12, 2022
Recap: Viveve Medical Q1 Earnings
Benzinga Insights
Viveve Medical Q1 EPS $(0.67), Inline, Sales ...
Benzinga Newsdesk
Earnings Scheduled For May 12, 2022
Benzinga Insights
Wednesday, April 27, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Friday, March 18, 2022
Looking Into Viveve Medical's Return On Invested Capital
Benzinga Insights
Thursday, March 17, 2022
Recap: Viveve Medical Q4 Earnings
Benzinga Insights
Earnings Scheduled For March 17, 2022
Benzinga Insights
Wednesday, March 16, 2022
Earnings Preview For Viveve Medical
Benzinga Insights
Thursday, March 10, 2022
VIVE: Potential game-changer for stress urinary incontinence in women
Zacks Small Cap Research
Tuesday, December 28, 2021
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, December 20, 2021
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Tuesday, December 14, 2021
Viveve Announces Completion Of Full Enrollmen...
Benzinga Newsdesk
Thursday, November 11, 2021
Viveve Medical Q3 EPS $(0.67) Misses $(0.61) ...
Benzinga Newsdesk
Earnings Scheduled For November 11, 2021
Benzinga Insights
Thursday, October 28, 2021
Viveve Reports Issued New Device, Methods Pat...
Benzinga Newsdesk
Thursday, October 21, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, October 08, 2021
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Shanthi Rexaline
Show More